Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer

Author: Bailey Howard   Attia Steven   Love Richard   Fass Terri   Chappell Rick   Tutsch Kendra   Harris Linda   Jumonville Alcee   Hansen Richard   Shapiro Gary   Stewart James  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.62, Iss.1, 2008-06, pp. : 149-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content